New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
20.39
0.07
−0.34%
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 1.95% in Q3 FY26, against a low of 1.91% in Q2 FY26.
ROEROIC
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 5.6% | 5.7% | 2.4% | 2.5% |
| ROIC | 3.0% | 3.0% | 1.9% | 2.0% |
Debt
Net debt is 18.60× a year’s EBITDA. Debt is 0.86× equity, against 0.96× in Q1 FY26.
Debt / equityNet debt / EBITDA
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.9× | 1.0× | 1.0× | 0.9× |
| Net debt / EBITDA | 21.2× | 21.0× | 98.1× | 18.6× |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has grown 12.0%; book value has fallen 5.01%.
RevenueBook value
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Book value | 1.0× | 0.9× | 0.9× | 0.9× |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 2.52% | 2.40% | 5.69% | 5.59% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 4 | 6 | 5 | |
| 1.30% | 1.21% | 2.89% | 2.88% | ||
ROIC |
1.95% | 1.91% | 3.01% | 3.04% | |
Return on Tangible Assets |
1.44% | 1.29% | 3.04% | 3.06% | |
Free Cash Flow per Share |
(0.93) | (1.10) | (0.52) | (0.24) | |
Free Cash Flow |
(236.90) | (277.23) | (131.42) | (57.20) | |
Capital Expenditures |
(637.47) | (648.80) | (498.13) | (405.82) | |
| Other line items | |||||
Cash ROIC |
(4.45%) | (4.94%) | (2.36%) | (1.05%) | |
Tax Rate |
(0.03) | (0.04) | (0.01) | (0.01) | |
Selling, General and Administrative Expense of Revenue |
6.87% | 7.00% | 6.87% | 6.93% | |
Share Based Compensation of Revenue |
1.54% | 1.53% | 1.45% | 1.47% | |
Interest Coverage |
1.41 | 1.35 | 2.26 | 2.28 | |
Operating CF/Net income |
5.60 | 5.68 | 2.35 | 2.24 | |
Depreciation/Fixed assets |
0.05 | 0.04 | 0.04 | 0.04 | |
Capex/Depreciation |
(2.82) | (3.10) | (2.53) | (2.17) | |
Revenue per Share |
3.60 | 3.41 | 3.22 | 3.21 | |
Operating CF per Share |
1.57 | 1.47 | 1.45 | 1.44 | |
Capex per Share |
(2.49) | (2.57) | (1.98) | (1.68) | |
Capex to Sales |
0.69 | 0.75 | 0.61 | 0.52 |
Columns are period end dates · fundamentals updated Nov 18, 2026